Home>>Signaling Pathways>> Others>>Meta-Topolin (m-Topolin)

Meta-Topolin (m-Topolin) (Synonyms: 6-m-Hydroxybenzylaminopurine, 6-meta-Hydroxybenzylaminopurine, m-Topolin)

Catalog No.GC30138

Meta-Topolin (m-Topolin) (m-Topolin) is a highly active aromatic cytokinin.

Products are for research use only. Not for human use. We do not sell to patients.

Meta-Topolin (m-Topolin) Chemical Structure

Cas No.: 75737-38-1

Size Price Stock Qty
10mM (in 1mL DMSO)
$46.00
In stock
50mg
$42.00
In stock
100mg
$60.00
In stock
500mg
$168.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Meta-Topolin (m-Topolin) is a highly active aromatic cytokinin.

Meta-Topolin is first isolated from poplar leaves. Meta-Topolin is a natural constituent of plant tissues, together with its 9-β-D-ribofuranosyl and 9-β-v-glucopyranosyl derivatives. Meta-topolin is more active than zeatin and benzyladenine in the promotion of shoot formation in plant tissue cultures[1]. In Spathiphyllum floribundum, shoot production in media with BAP and meta-topolin is very similar[2].

[1]. Strnad M, et al. Meta-topolin, a highly active aromatic cytokinin from poplar leaves (Populus × canadensis Moench., cv. Robusta). Phytochemistry 45(2):213-218. [2]. Werbrouck S, et al. Meta‐topolin, an alternative to benzyladenine in tissue culture? 1996. 98 (2):291-297.

Reviews

Review for Meta-Topolin (m-Topolin)

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Meta-Topolin (m-Topolin)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.